Net profit of Windlas Biotech rose 11.62% to Rs 15.66 crore in the quarter ended September 2024 as against Rs 14.03 crore during the previous quarter ended September 2023. Sales rose 22.49% to Rs 187.00 crore in the quarter ended September 2024 as against Rs 152.67 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 187.00 | 152.67 | 22 |
| OPM % | 12.33 | 12.24 | - |
| PBDT | 26.79 | 21.64 | 24 |
| PBT | 20.29 | 18.31 | 11 |
| NP | 15.66 | 14.03 | 12 |